Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2026 10:30 ET | Source: Exousia Pro, Inc.

NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test

Exousia Pro, OTCPK: MAJI, announces the commencement of the first critical phase in bringing its revolutionary cancer screening test to the global market.
March 16, 2026 10:15 ET | Source: Exousia Pro, Inc.

Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value

OTC.MAJI Announces landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value.
March 05, 2026 13:00 ET | Source: Exousia Pro, Inc.

Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions

(OTCPK: MAJI) announces several pivotal corporate milestones aimed at enhancing shareholder value and expanding the company’s commercial footprint.
February 10, 2026 10:30 ET | Source: Exousia Pro, Inc.

Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition

Exousia Pro, Inc. (OTCID: MAJI to acquire an established telehealth organization.